// App-Quantinova.ai

: Determination of the Origin of the t(1;19) TCF3-PBX1 Fusion By Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL)

Researchers

Presenter

  • Daniel Hein

Principal Investigators

  • Karin Dreisig

  • Shai Izraeli

  • Kjeld Schmiegelow

  • Arndt Borkhardt

  • Ute Fischer

Medical Centers

  • Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany

  • Department of Pediatrics and Adolescent Medicine,The Juliane Marie Centre, Rigshospitalet, Copenhagen University Hospital and University of Copenhagen, Copenhagen, Denmark

  • Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel

  • The Dora and Gregorio Chair of Hematological Malignancies Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Locations

  • Germany

  • Denmark

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Immunoglobulin heavy-chain variable region gene

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved